Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.

about

Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4.

Item

http://www.wikidata.org/entity/Q40150202

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Drug fever after cancer chemot ...... on posttreatment days 3 and 4.

@en

type

Item

label

Drug fever after cancer chemot ...... on posttreatment days 3 and 4.

@en

prefLabel

Drug fever after cancer chemot ...... on posttreatment days 3 and 4.

@en

P1476

Drug fever after cancer chemot ...... on posttreatment days 3 and 4.

@en

P2093

Daiki Ogawara

http://www.w3.org/2001/XMLSchema#string

Katsumi Nakatomi

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Tsukamoto

http://www.w3.org/2001/XMLSchema#string

Kazuto Ashizawa

http://www.w3.org/2001/XMLSchema#string

Kosuke Mizoguchi

http://www.w3.org/2001/XMLSchema#string

Mikio Oka

http://www.w3.org/2001/XMLSchema#string

Minoru Fukuda

http://www.w3.org/2001/XMLSchema#string

Shigeru Kohno

http://www.w3.org/2001/XMLSchema#string

Shinnosuke Takemoto

http://www.w3.org/2001/XMLSchema#string

Shiro Ueno

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.

Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer.

Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia.

Colony-stimulating factors for febrile neutropenia during cancer therapy.

Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature.

Fever and aging.

Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.

Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.

Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC inf

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.

P2888

s00520-015-2820-8

P304

615-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-015-2820-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006522306

http://www.w3.org/2001/XMLSchema#string

P698

26108172

http://www.w3.org/2001/XMLSchema#string